Management of locally advanced rectal cancer: ASCO guideline

AJ Scott, EB Kennedy, J Berlin, G Brown… - Journal of Clinical …, 2024 - ascopubs.org
ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …

Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer

D Dayde, I Tanaka, R Jain, MC Tai… - International journal of …, 2017 - mdpi.com
The standard of care in locally advanced rectal cancer is neoadjuvant chemoradiation
(nCRT) followed by radical surgery. Response to nCRT varies among patients and …

Effect of self-efficacy intervention on quality of life of patients with intestinal stoma

S Xu, Z Zhang, A Wang, J Zhu, H Tang… - Gastroenterology …, 2018 - journals.lww.com
Colorectal carcinoma is one of the most common malignancies worldwide and the most
prevalent cause of cancer mortality in China. The Miles operation and permanent colostomy …

The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer

I Santiago, M Barata, N Figueiredo, O Parés… - European …, 2020 - Springer
Objectives To measure the diagnostic performance of a new radiologic pattern on restaging
magnetic resonance (MR) high-resolution T2-weighted imaging (T2-WI)—the split scar sign …

Molecular and kinetic analyses of circulating tumor cells as predictive markers of treatment response in locally advanced rectal cancer patients

BC Troncarelli Flores, V Souza e Silva, E Ali Abdallah… - Cells, 2019 - mdpi.com
Neoadjuvant chemoradiation (NCRT) followed by total mesorectal excision is the standard
treatment for locally advanced rectal cancer (LARC). To justify a non-surgical approach …

Comparison of guidelines for the management of rectal cancer

E Luzietti, G Pellino, S Nikolaou, S Qiu, S Mills… - BJS open, 2018 - academic.oup.com
Background Overall survival from rectal cancer has almost doubled over the last 20 years.
Following recommendations in management guidelines plays some part in this, but the …

The efficacy of miR-20a as a diagnostic and prognostic biomarker for colorectal cancer: a systematic review and meta-analysis

L Moody, S Dvoretskiy, R An, S Mantha, YX Pan - Cancers, 2019 - mdpi.com
Background: MicroRNAs have altered expression levels in various diseases and may play
an important role in the diagnosis and prognosis of colorectal cancer (CRC). Methods: We …

Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer

R Clifford, N Govindarajah, JL Parsons… - Journal of British …, 2018 - academic.oup.com
Background With the well established shift to neoadjuvant treatment for locally advanced
rectal cancer, there is increasing focus on the use of radiosensitizers to improve the efficacy …

[HTML][HTML] Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?

I Imam, K Hammarström, T Sjöblom… - Radiotherapy and …, 2021 - Elsevier
Abstract Introduction The Neoadjuvant rectal (NAR) score is a new surrogate endpoint to be
used in clinical trials for early determination of treatment response to different preoperative …

'Watch and wait'in rectal cancer: summary of the current evidence

J On, EH Aly - International Journal of Colorectal Disease, 2018 - Springer
Background The management of rectal cancer has evolved considerably over the last few
decades with increasing use of neoadjuvant chemoradiotherapy (nCRT). Complete clinical …